Renal Medical Devices And Services Market Size (2024 - 2029)

Renal Medical Devices & Services Market Analysis

The Renal Medical Devices And Services Market is expected to register a CAGR of 6.40% during the forecast period.

The major factors driving the growth of renal medical devices and services include the rising prevalence of kidney diseases, the growing geriatric population, and the increasing incidences of diabetes and high blood pressure.

Kidney disease affects a significant proportion of the global population. It has increased in recent decades due to the growing burden of various chronic conditions, such as diabetes, obesity, and high blood pressure, which leads to chronic kidney diseases. For instance, according to the data published by the Kidney Foundation Canada in January 2022, one in every ten Canadians suffers from renal disease, 4 million people each year.

Similarly, according to the World Health Organization, in May 2024, in the European Region, high blood pressure is the foremost risk factor for disability, accounting for 13% of disabilities. Therefore, the high risk of hypertension in Europe may lead to an increased risk of kidney failure as hypertension leads to constriction of the renal blood vessels, thereby anticipating an increase in anticipated to increase the adoption of renal devices and services.

Further, high blood sugar from diabetes can damage blood vessels in the kidneys and nephrons, affecting the function of kidney blood vessels and nephrons. Many people with diabetes also develop high blood pressure, leading to kidney damage and kidney failure. Hence the growing burden of diabetes is expected also to increase kidney diseases which likely propel the market's growth. For instance, as per the 2022 report from the International Diabetic Federation (IDF), by 2030 and 2045, the number of diabetic population around the world was projected to reach 643 million and 783 million respectively. Hence, the expected rise of diabetics, which causes kidney diseases, is likely to propel the demand for renal medical devices and services over the forecast period.

Additionally, market players are adopting various strategies such as product launches, mergers, acquisitions, and partnerships to increase the access of their devices to the end users, which is expected to boost market growth over the forecast period. For instance, in January 2022, ReCor Medical, a subsidiary of Otsuka Medical Devices Co. Ltd., launched the Paradise Ultrasound Renal Denervation System for treating uncontrolled hypertension in Germany.

Hence, the increasing burden of kidney diseases and diabetes coupled with strategic activities by the market players is expected to boost market growth over the forecast period. However, reimbursement issues and lack of awareness in developing and under-developed regions are expected to restrain the market over the forecast period.

Renal Medical Devices & Services Industry Segmentation

As per the scope of the market, renal medical devices are used to treat or alleviate renal disorders. These medical devices are used in the care and treatment of people with kidney failure.

The Renal Medical Devices and Services Market is segmented by product, application, and geography. By product, the market is segmented into dialysis equipment, renal denervation devices, wearable artificial kidney devices, and distal embolic protection devices. By application, the market is segmented into kidney failure, chronic kidney disease, end-stage kidney disease, renal kidney stone disease, hypertension, diabetes, and others. By geography, the market is segmented into North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers the estimated market sizes and trends of 17 countries across major regions globally. The report offers the value (in USD) for the above segments.